Skip to main content
SpringerLink
Log in

Effects of clofibric acid and bezafibrate administration on activities of alkaline phosphatase and other enzymes in livers of rats

  • Original Contributions
  • Published:
Research in Experimental Medicine

Summary

Administration of clofibric acid and bezafibrate to rats lowers plasma lipids, increases the liver weight, and causes a slight decrease in the activity of alkaline phosphatase in plasma. However, both these drugs increase the activity of alkaline phosphatase in liver over threefold. The activity of other enzymes did not change by the same magnitude. The increase in the alkaline phosphatase activity in liver tissue appears to be due to increase in the activity of this enzyme in parenchymal cells. Clofibric acid and bezafibrate increase the activity of bilirubin-glucuronyl transferase activity over twofold in liver microsomes.

It is thus evident that both these drugs cause similar changes in various enzyme activities in liver even though bezafibrate has been reported to have a much shorter biologic halflife than clofibric acid.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Abshagen U, Bablok W, Koch K, Lang PD, Schmidt HAE, Stork H (1979) Disposition pharmacokinetics of bezafibrate in man. Eur J Clin Pharmacol 16:31–38

    PubMed  Google Scholar 

  • Ahmed Z, King EJ (1959) Placental phosphatases. Biochim Biophys Acta 34:313–325

    PubMed  Google Scholar 

  • Anthony L, Schmucker D, Mooney J, Jones A (1978) A quantitative analysis of fine structure and drug metabolism in livers of clofibrate-treated young adult and retired breeder rats. J Lipid Res 19:154–165

    PubMed  Google Scholar 

  • Avoy DR, Swyrd EA, Gould RG (1965) Effects ofα-p-chlorophenoxyisobutyrylethyl ester (CPIB) with and without androsterone biosynthesis in liver. J Lipid Res 6:369–376

    Google Scholar 

  • Bergmeyer HU (1970) In: Methoden der enzymatischen Analyse, Vol I, II. Verlag Chemie, Weinheim, Bergstraße

    Google Scholar 

  • Berndt J, Gaumert R, Still J (1978) Mode of action of lipid-lowering agents, clofibrate and BM 15075 on cholesterol biosynthesis in rat liver. Atherosclerosis 30:147–152

    PubMed  Google Scholar 

  • Berry MN, Friend DS (1969) High-yield preparation of isolated liver parenchymal cells. A biochemical and fine structural study. J Cell Biol 43:506–520

    PubMed  Google Scholar 

  • Best MM, Duncan CH (1964) Hypolipemia and hepatomegaly from ethyl chlorophenoxyisobutyrate (CPIB) in the rat. J Lab Clin Med 64:634–642

    PubMed  Google Scholar 

  • Bolzano K, Krempler F, Schellenberg B, Schlierf (1979) In: Greten H, Lang PD, Schettler G (Hrsg) Lipoproteine und Herzinfarkt. Witzstrock, Baden-Baden, S 134–136

    Google Scholar 

  • Burch RE, Curran GL (1969) Hepatic acetoacetyl-CoA deacylase activity in rats fed ethyl chlorophenoxyisobutyrate (CPIB). J Lipid Res 10:668–673

    PubMed  Google Scholar 

  • Fahimi HD, Kalmbach P, Stegmeier K, Stork H (1979) In: Greten H, Lang PD, Schettler G (Hrsg) Lipoproteine und Herzinfarkt. Witzstrock, Baden-Baden, S 66–77

    Google Scholar 

  • Foliot A, Drocourt J-L, Etienne JP, Housset E, Fiessinger JN, Christoforov B (1977) Increase in the hepatic glucuronidation and clearance of bilirubin in clofibrate-treated rats. Biochem Pharmacol 26:547–549

    PubMed  Google Scholar 

  • Gear RL, Albert AD, Bednarek (1974) The effect of hypocholesterolemic drug clofibrate on liver mitochondrial biogenesis. J Biol Chem 249:6495–6504

    PubMed  Google Scholar 

  • Hellman L, Zumoff B, Kessler G, Kara E, Rubin IL, Rosenfeld RS (1963) Reduction of cholesterol and lipids in man by ethyl-chlorophenoxyisobutyrate. Ann Int Med 59:477–493

    PubMed  Google Scholar 

  • Hess R, Stäubli W, Reiss W (1965) Nature of hepatomegalic effect produced by ethylchlorophenoxyisobutyrate in the rat. Nature 208:856–858

    PubMed  Google Scholar 

  • Hodson AW, Latner AL, Raine L (1961) Isoenzymes of alkaline phosphatase. Clin Chim Acta 7:255–261

    Google Scholar 

  • Kaplan MM, Righetti A (1970) Induction of rat liver alkaline phosphatase, the mechanism of serum elevation in bile duct obstruction. J Clin Invest 49:508–516

    PubMed  Google Scholar 

  • Lazarow P (1978) Rat liver peroxisomes catalyze theβ-oxidation of fatty acids. J Biol Chem 253:1522–1528

    PubMed  Google Scholar 

  • Lazarow P (1979) In: Greten H, Lang PD, Schettler G (Hrsg) Lipoproteine und Herzinfarkt. Witzstrock, Baden-Baden, S 100–104

    Google Scholar 

  • Lazarow P, de-Duve C (1976) A fatty acyl-CoA oxidizing system in rat liver peroxisomes, enhancements by clofibrate, a hypolipidemic drug. Proc Natl Acad Sci USA 73:2043–2046

    PubMed  Google Scholar 

  • Lowry OH, Rosebrough NJ, Farr L, Randall RJ (1951) Protein measurement with folin-phenol reagent. J Biol Chem 193:265–275

    PubMed  Google Scholar 

  • Moss DW, Walli AK (1969) Intermediates in the hydrolysis of ATP by human alkaline phosphatase. Biochem Biophys Acta 191:476–477

    PubMed  Google Scholar 

  • Nordlie RC, Arion WJ (1966) In: Colowick SP, Kaplan NO (eds) Methods in enzymology, vol 9. Academic Press, New York, p 619

    Google Scholar 

  • Omura T, Sato R (1964) The carbon monoxide binding pigment of liver microsomes. Solubilization, purification and its properties. J Biol Chem 239:2379–2385

    PubMed  Google Scholar 

  • Platt DS, Thorp JM (1966) Changes in the weight and composition of liver in the rat, dog and monkey treated with chlorophenoxyisobutyrate. Biochem Pharmacol 15:915–925

    PubMed  Google Scholar 

  • Posen S (1967) Alkaline phosphatase. Ann Int Med 67:183–202

    PubMed  Google Scholar 

  • Reddy J, Krishnakantha T (1975) Hepatic peroxisome proliferation. Induction by two novel compounds structurally unrelated to clofibrate. Science 190:787–789

    PubMed  Google Scholar 

  • Roy FP van, Heirwegh KPM (1968) Determination of bilirubin glucuronide and assay of glucuronyltransferase with bilirubin as acceptor. Biochem J 107:507–518

    PubMed  Google Scholar 

  • Schade RWB, Demacker PNM, Van'T Laar A (1975) Reduction of serum alkaline phosphatase by clofibrate. Lancet I:862–863

    Google Scholar 

  • Schade RWB, Demacker PNM, Van'T Laar A (1977) Clofibrate effect on alkaline phosphatase. Bone or liver fraction. N Engl J Med 297:669

    Google Scholar 

  • Schimassek H (1963) Metabolite des Kohlenhydratstoffwechsels der isoliert perfundierten Rattenleber. Biochem Z 336:460–467

    PubMed  Google Scholar 

  • Schimassek H, Hofer G, Walli AK (1971) In: Martini GA, Bode Ch (eds) Metabolic changes induced by alcohol. Springer, Heidelberg, pp 157–165

    Google Scholar 

  • Stegmeier K, Stork H, Lenz H, Leuschner F, Liede V (1979) In: Greten H, Lang PD, Schettler G (Hrsg) Lipoproteine und Herzinfarkt. Witzstrock, Baden-Baden, S 78–84

    Google Scholar 

  • Walli AK, Birkmann K, Schimassek H (1974) Glycogen metabolism in isolated rat parenchymal cells. Hoppe Seylers Z Physiol Chem 355:1264

    Google Scholar 

  • Walli AK, Schimassek H (1976) Glycogen metabolism in isolated parenchymal cells. In: Tager JM, Söling HD, Williamson JR (eds) Use of isolated liver cells and kidney tubules in metabolic studies. North Holland Publ Co, Amsterdam, pp 426–429

    Google Scholar 

  • Whitaker KB, Costa D, Moss DW (1979) Selective effects of clofibrate on alkaline phosphatase isoenzymes in serum. Clin Chim Acta 94:191–196

    PubMed  Google Scholar 

  • White LW (1971) Regulation of hepatic cholesterol biosynthesis by clofibrate administration. J Pharmacol Exp Ther 178:361–370

    PubMed  Google Scholar 

  • Wilkinson JH (1965) In: Isoenzymes. E & FN Spon Ltd, London, pp 104–119

    Google Scholar 

  • Wootton AM, Neale G, Moss DW (1975) Some properties of alkaline phosphatases in parenchymal and biliary tract cells separated from rat liver. Clin Chim Acta 61:183–190

    PubMed  Google Scholar 

  • Zumoff B (1977) Effect of clofibrate on plasma levels of alkaline phosphatase. N Engl J Med 297:669

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Dept. of Clinical Chemistry, Center of Internal Medicine, University of Göttingen, Robert-Koch-Str. 40, D-3400, Göttingen, Federal Republic of Germany

    Autar K. Walli & D. Seidel

Authors
  1. Autar K. Walli
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. D. Seidel
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Walli, A.K., Seidel, D. Effects of clofibric acid and bezafibrate administration on activities of alkaline phosphatase and other enzymes in livers of rats. Res. Exp. Med. 179, 153–161 (1981). https://doi.org/10.1007/BF01851983

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01851983

Key words

Search

Navigation